These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22104314)

  • 1. Myelodysplastic syndrome of del 20q with plasma cell dysplasia.
    Saito N; Higashiura K; Ehata K; Kurosawa S; Honma K; Abe M; Kimura A; Suzuki M; Nakamura S; Shiku H; Kean Ooi H
    J Clin Exp Hematop; 2011; 51(2):141-5. PubMed ID: 22104314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
    Kanagal-Shamanna R; Yin CC; Miranda RN; Bueso-Ramos CE; Wang XI; Muddasani R; Medeiros LJ; Lu G
    Cancer Genet; 2013; 206(1-2):42-6. PubMed ID: 23357231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factor analysis in myelodysplastic syndrome patients with del(20q): prognosis revisited.
    Liu YC; Ito Y; Hsiao HH; Sashida G; Kodama A; Ohyashiki JH; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Nov; 171(1):9-16. PubMed ID: 17074585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distribution of abnormal cell clone with deletion of chromosome 20q in marrow cell lineages and apoptosis cells in myelodysplastic syndrome].
    Qin L; Wang C; Qin YW; Xie KC; Yan SK; Gao YR; Wang XR; Zhao CX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):551-4. PubMed ID: 18549627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of bone marrow cell morphology in a cohort of patients with isolated idic(20q-) karyotypic abnormalities.
    Liu D; Pan J; Wu C; Liang J; Wang J; Chen S; Chen Z
    Ann Hematol; 2019 Mar; 98(3):605-614. PubMed ID: 30483862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients With a History of Chemotherapy and Isolated del(20q) With Minimal Myelodysplasia Have an Indolent Course.
    Courville EL; Singh C; Yohe S; Linden MA; Naemi K; Berger M; Ustun C; McKenna RW; Dolan M
    Am J Clin Pathol; 2016 Apr; 145(4):459-66. PubMed ID: 27124938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characteristics and prognostic analysis in 213 myeloid malignancy patients with del(20q): a report of a single-center case series.
    Pan J; Wu C; Xue Y; Qiu H; Chen S; Zhang J; Bai S; Wu Y; Wang Y; Shen J; Gong Y
    Cancer Genet; 2014 Mar; 207(3):51-6. PubMed ID: 24699042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and cytogenetic features of 29 cases of myelodysplastic syndrome associated with del(20q)].
    Qin S; Liu SH; Bo LJ; Liu XP; Li CW; Dai Y; He GS; Shao ZH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):171-2. PubMed ID: 15079804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elliptocytosis in myelodysplastic syndrome associated with translocation (1;5)(p10;q10) and deletion of 20q.
    Ishida F; Shimodaira S; Kobayashi H; Saito H; Kaku M; Kanzaki A; Yawata Y; Kitano K; Kiyosawa K
    Cancer Genet Cytogenet; 1999 Jan; 108(2):162-5. PubMed ID: 9973947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases.
    Braun T; de Botton S; Taksin AL; Park S; Beyne-Rauzy O; Coiteux V; Sapena R; Lazareth A; Leroux G; Guenda K; Cassinat B; Fontenay M; Vey N; Guerci A; Dreyfus F; Bordessoule D; Stamatoullas A; Castaigne S; Terré C; Eclache V; Fenaux P; Adès L
    Leuk Res; 2011 Jul; 35(7):863-7. PubMed ID: 21396711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features?
    Wattel E; Laï JL; Hebbar M; Preudhomme C; Grahek D; Morel P; Bauters F; Fenaux P
    Leuk Res; 1993 Nov; 17(11):921-6. PubMed ID: 8231232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact.
    Bacher U; Haferlach T; Schnittger S; Zenger M; Meggendorfer M; Jeromin S; Roller A; Grossmann V; Krauth MT; Alpermann T; Kern W; Haferlach C
    Br J Haematol; 2014 Mar; 164(6):822-33. PubMed ID: 24372512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells.
    White NJ; Nacheva E; Asimakopoulos FA; Bloxham D; Paul B; Green AR
    Blood; 1994 May; 83(10):2809-16. PubMed ID: 8180377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion(20q) as the sole abnormality in plasma cell myeloma is not associated with plasma cells as identified by cIg FISH.
    White JS; Zordan A; Batzios C; Campbell LJ
    Cancer Genet; 2012 Dec; 205(12):644-52. PubMed ID: 23200818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interphase FISH does not improve the detection of DEL(5q) and DEL(20q) in myelodysplastic syndromes.
    Douet-Guilbert N; Herry A; LE Bris MJ; Guéganic N; Bovo C; Morel F; DE Braekeleer M
    Anticancer Res; 2011 Mar; 31(3):1007-10. PubMed ID: 21498729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study.
    Mullier F; Daliphard S; Garand R; Dekeyser M; Cornet Y; Luquet I; Talmant P; Richebourg S; Jamar M; Dogné JM; Chatelain C; Michaux L; Chatelain B
    Ann Hematol; 2012 Feb; 91(2):203-13. PubMed ID: 21744002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation.
    Gupta R; Soupir CP; Johari V; Hasserjian RP
    Br J Haematol; 2007 Oct; 139(2):265-8. PubMed ID: 17764468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of the del(20q) chromosome in hematologic disorders.
    Aatola M; Armstrong E; Teerenhovi L; Borgström GH
    Cancer Genet Cytogenet; 1992 Aug; 62(1):75-80. PubMed ID: 1521239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
    Saunders K; Czepulkowski B; Sivalingam R; Hayes JP; Aldouri M; Sekhar M; Cummins M; Ho A; Mufti GJ
    Cancer Genet Cytogenet; 2005 Jan; 156(2):154-7. PubMed ID: 15642396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion (20q) as the sole abnormality in Waldenström macroglobulinemia suggests distinct pathogenesis of 20q11 anomaly.
    Liu YC; Miyazawa K; Sashida G; Kodama A; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Aug; 169(1):69-72. PubMed ID: 16875940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.